Zdrowie i gospodarka · 15/07/2020
FDA Releases Draft Guidance on Biomarkers and Surrogate Endpoints for New Animal Drugs
The FDA is releasing a draft guidance document that outlines its current thinking on using biomarkers and surrogate endpoints in clinical studies to support the effectiveness of new animal drugs.